Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2013; 19(15): 2348-2354
Published online Apr 21, 2013. doi: 10.3748/wjg.v19.i15.2348
Table 3 Multivariate analysis for resource use prevalence among patients at first progression vs baseline1
Resource1BetaOdds95%CIP
estimateratioLower boundUpper boundvalue
Chemotherapy1.19623.30741.46257.47950.00412
Somatostatin analogs0.52981.69860.80383.58920.1652
Surgery0.45511.57630.76323.25560.2188
Hospitalization0.32271.38080.69202.75500.3599
Other physician visit0.73362.08260.91854.72210.0790